Free Trial
OTCMKTS:BFNH

BioForce Nanosciences Q2 2026 Earnings Results & Report

BioForce Nanosciences logo
$8.25 -0.15 (-1.79%)
As of 10:04 AM Eastern

BioForce Nanosciences reported Q2 2026 earnings on August 10, 2026. The company reported EPS of $0.01.

Earnings Announcement Details

Quarter
Q2 2026
Report Date
Time
After Market Closes

BioForce Nanosciences EPS Results

Actual EPS
$0.01
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

BioForce Nanosciences Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Conference Call Resources

BioForce Nanosciences Q2 2026 Earnings FAQ

BioForce Nanosciences (OTCMKTS:BFNH) reported earnings of $0.01 per share for Q2 2026. The report was announced on Monday, August 10, 2026.

BioForce Nanosciences Earnings Headlines

Your book attached
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link. He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing.tc pixel
BioForce Nanosciences Delays Annual 10-K Filing
See More BioForce Nanosciences Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like BioForce Nanosciences? Sign up for Earnings360's daily newsletter to receive timely earnings updates on BioForce Nanosciences and other key companies, straight to your email.

About BioForce Nanosciences

BioForce Nanosciences (OTCMKTS:BFNH), Inc. develops nanotechnology tools and systems designed for research in life sciences, materials science and related fields. The company’s technologies are intended to support the controlled manipulation, deposition and analysis of very small quantities of biological and chemical materials.

Its product portfolio has included nanoscale patterning and fluid-handling systems, including the Nano eNabler platform. These tools are designed for applications such as creating biological arrays, depositing samples and reagents, and conducting research involving cells, proteins, DNA and other materials at the micro- and nanoscale.

BioForce Nanosciences was based in the United States and focused primarily on serving scientific, academic and industrial research markets. Publicly available information about its current operations, geographic reach and leadership is limited.

View BioForce Nanosciences Profile